Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Determine which is better for saving: Cash App or a traditional savings account. This guide provides insights to help you decide.
25,577 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Qualcomm is shifting focus from phones to AI compute, targeting massive new markets. This article breaks down the pla...
Anthropic’s Fable returns to service as the U.S. eases export controls, but a cloudy policy framework keeps investors...
Qualcomm unveils a bold AI-backed diversification plan led by CIO Attila Tinic, targeting data centers, automotive an...
XRP faces a sharp pullback in derivatives betting even as XRPL expands its institutional footprint, targeting a $4 bi...
Copper prices rise with AI hardware bets, placing copper shadowing hyperscaler stocks at the center of market debate....
Moonshot AI unveils Kimi K3, a new open Chinese AI model that could alter the competitive balance in the AI race. Inv...
A surge in AI inference demands is reshaping Google Cloud’s economics, forcing investors to weigh faster growth again...
November 2025 marks a new milestone as the Bitcoin Lightning Network surpasses $1B in monthly volume, signaling a shi...
When pop culture and personal finance collide, even a Vegas celebration becomes a lesson in budgeting, sponsorships, ...
Markets shift from mega-cap tech to overlooked small firms. This story highlights three small-cap ETFs to buy before ...
AutoZone beat on revenue but missed top-line estimates, while margins narrowed and shares fell. The focus: margins cr...